PATENT CLAIM ANALYSIS

Application Number: 16020875
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2020-01
Patent Classification: ["426", "655000"]

Abstract:
Embodiments herein relate to a concentrate of a kavalactone and methods for making the same, as well as products containing the concentrate, the concentrate comprising a noble kava comprising kavain, dihydrokavain, methysticin, dihydromethysticin, yangonin, and desmethoxyyangonin, wherein the concentrate comprises 10% or more of the kavalactone as measured by HPLC.

Claim (Index 35):
The product of  claim 31 , wherein the THC extract or the CBD extract is obtained from hemp, hemp stalk, hemp stem, hemp seed, cannabis, cannabis stalk, cannabis stem, cannabis seed, cannabis flower or combinations thereof.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 94.0
- Lexical Diversity: 1.57895
- Patent Class: 426.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13163901', '10408900', '10263579', '10273943', '10273981']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7647805619433645
- 35 USC 102 Novelty (BERT): 0.5341053268956348
- Combined Prediction Score: 0.7417130384385916
- Mean Citation Score: 262.251138
- Max Citation Score: 320.87875
- Similarity Product: 129.48358092326671

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test